Business
PTC Therapeutics' 2022 STRIVE Awards Program Funds Initiatives Supporting the Duchenne Patient Community
- 2022 recipients include patient advocacy organizations from Brazil, Greece, Turkey, and the U.K. - SOUTH PLAINFIELD, N.J., Sept. 7, 2022 /PRNewswire/ -- PTC
About this update from Ptc Therapeutics, Inc.
[{"type":"text","content":"- 2022 recipients include patient advocacy organizations from Brazil, Greece, Turkey, and the U.K. -\nSOUTH PLAINFIELD, N.J., Sept. 7, 2022 /PRNewswire/ -- PTC Therapeutics, Inc. (NASDAQ: PTCT) today announced the four recipients of its 2022 STRIVE Awards for Duchenne Muscular Dystrophy. The STRIVE program provides grants to non-profit patient advocacy organizations serving the Duchenne community. This year, grants will fund projects focused on formal learning, psychological support, sexuality, and skills-based training for people with Duchenne. \n\n \n \n \n \n \n \n\n \n\"We are proud to support the 2022 grant recipients for their work in the Duchenne community through our STRIVE Awards program. They have shown the broad range of needs in the Duchenne community, including programs supporting adults living with Duchenne,\" said Mary Frances Harmon, senior vice president, Corporate Relations, PTC Therapeutics. \"The positive impact of the STRIVE grants will be across four countries this year, and we are privileged to provide the organizations with support to make their innovative projects a reality.\"\nThe categories for the 2022 STRIVE Awards are 'Innovative' for programs that help to address the unmet needs of the rare disease community, and 'Transition to Adulthood' for programs that support young people with Duchenne as they transition into independent adults. 'Transition to Adulthood' is a category introduced last year to celebrate the initiatives that support those living with Duchenne to lead independent, fulfilling, and rewarding lives. This year, PTC received 40 applications from organizations around the world.\nThe 2022 STRIVE Awards recipients are:\nInnovative Category:\nBrazil -The State of Ceará Muscular Dystrophy Association (ACDM) will launch \"Project Facilitate,\" a program focused on rehabilitating students with Duchenne into formal education and giving them the opportunity to achieve the educational objectives for their academic level. The project offers students greater autonomy to develop academically and socially.Turkey - Neuromuscular Disorders Association of Turkey (KASDER) first received the STRIVE Award in 2018 to setup their online psychological support system for Turkish-speaking people with Duchenne around the world. As second-time recipients of the grant, their 2022 project will focus on an expansio...